年轻前列腺癌患者主动监测期间升级风险更低:荟萃分析与系统综述
该系统综述与荟萃分析纳入8项研究共6522例中位年龄65.8岁(范围41-86岁)的低危前列腺癌主动监测患者,评估年龄与Gleason升级及活检进展的相关性。总体而言,年轻患者Gleason评分升级和活检进展风险更低。
要点
- 年轻患者主动监测期间疾病升级风险更低,支持其作为主动监测候选人群。
核心结论
- 年轻前列腺癌患者在接受主动监测期间Gleason评分升级和活检进展的风险均低于年长患者。
研究设计与样本
- 系统综述与荟萃分析,纳入8项符合标准的研究,共6522例患者,中位年龄65.8岁(范围41-86岁)。
临床怎么用
- 对于低危前列腺癌年轻患者,主动监测期间可考虑其升级风险较低的特点进行个体化随访决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Active surveillance has become a popular option for patients with low risk prostate cancer. Our objective was to examine the correlation between age and the risk of Gleason upgrading and biopsy progression. A systematic search was conducted. Eight studies met our eligibility criteria including 6522 patients with a median age of 65.8 (41-86) years. Per decade decrease in age, the pooled odds ratio and hazard ratio (CI 95%) for Gleason upgrading were 0.83 (0.73-0.94) and 0.87 (0.82-0.92), and for biopsy progression were 0.80 (0.74-0.86) and 0.88 (0.79-0.99), respectively. Overall, younger patients have a lower risk of GS upgrading and biopsy progression.
引用
- Mahran A, Turk A, Buzzy C, et al. Younger Men With Prostate Cancer Have Lower Risk of Upgrading While on Active Surveillance: A Meta-analysis and Systematic Review of the Literature. Urology. 2018. PMID: 30056194. doi:10.1016/j.urology.2018.06.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。